Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
General Introduction | Shanghai Condlai Enterprise Development Group Co., Ltd. (referred to as Condlai; stock code 603987), founded in Wenzhou in 1987, is headquartered at No. 658 Gaolu, Jiangqiao Town, Jiading District, Shanghai. It is mainly engaged in the research and development, production, and sales of medical puncture instruments, mainly producing medical needles and puncture devices. The company is a leading enterprise in the manufacturing technology of medical puncture needles in China, It is one of the few domestic production enterprises with a complete industrial chain of medical puncture instruments. As the parent company of Kangdelai listed company, through capital operation and industrial operation, the company currently has more than 50 subsidiaries, all of which are enterprises engaged in the production and operation of medical puncture products. In terms of industry status, the company is not only responsible for/participated in the drafting of six national standards for disposable infusion sets, blood transfusions, syringes, injection needles, intravenous infusion needles, medical stainless needle tubes, but also participated in the drafting of disposable anesthesia needles, implantable drug delivery device specialized needles, biopsy needles, intravenous indwelling needles, sterile dental injection needles, dental cylindrical syringes Drafting of thirteen industry standards, including packaging materials for final sterilization of medical devices. The company has been rated as one of the "Top 100 Manufacturing Enterprises" by Shanghai for many consecutive years, and its products have been awarded titles such as "Shanghai Famous Brand Product", "Shanghai Famous Trademark", and "Excellent Brand Product of the National Industry Association". The company adheres to the quality policy of "creating KL brand and winning the trust of billions of users" and establishes a medical device quality management system in accordance with national regulations. At the same time, it has also established a research and development system that combines schools and enterprises, and has obtained over 200 domestic and international patents. It has been recognized as a "high-tech enterprise", "patent demonstration enterprise", "municipal level technology research and development center", and "Shanghai Science and Technology Little Giant Enterprise" in Shanghai. It has also received support from projects such as the Shanghai Huoju Plan and Shanghai High tech Achievement Transformation multiple times. Our products are sold to various provinces, autonomous regions, and direct markets in China, and are exported to over 50 countries and regions such as the United States, Europe, South America, the Middle East, and Southeast Asia, forming long-term and stable cooperative relationships. "Symbiosis, win-win situation, and common development" is the unchanging cultural concept of Kant cuisine. We will continue to adhere to the positioning of high-quality products and technological innovation, provide high-quality products and services for human health, and work hand in hand with our domestic and foreign counterparts to make new contributions to the further development of China's medical and health industry!. |
Headquarter | Shanghai |
Establish Date | 7/1/1998 |
Listed Code | 603987.SH |
Listed Date | 11/21/2016 |
Chairman | Zhang Xianmiao. |
CEO | Zhang Weixin. |
Website | www.kdlchina.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial